Rachel Culp‐Hill

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones et al. · Nature Medicine · 2018 · 768 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +9

Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Courtney L. Jones, Brett M. Stevens, Angelo D’Alessandro et al. · Cancer Cell · 2018 · 539 citations · Full text

Hematological Malignancy, Biochemistry, Medicine +5

p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression

Sung‐Hwan Moon, Chun‐Hao Huang, Shauna L Houlihan et al. · Cell · 2018 · 442 citations · Full text

Medicine, Mevalonate Pathway, Tumor Suppressor +4

The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

Tamilla Nechiporuk, Stephen E. Kurtz, Olga Nikolova et al. · Cancer Discovery · 2019 · 358 citations · Full text

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells

Brett M. Stevens, Courtney L. Jones, Daniel A. Pollyea et al. · Nature Cancer · 2020 · 282 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +6